Dato-DXd showed a 43% reduction in disease progression risk and a 21% reduction in death risk compared to chemotherapy in TNBC patients ineligible for immunotherapy. The TROPION-Breast02 trial ...
Discover Delcath’s innovative liver-targeted chemotherapy system and latest clinical data driving potential market expansion.
The hospital director, brokers, and patients?totaling 120 individuals?have been apprehended by police on charges of ...
East Idaho News on MSN
Common questions about lung cancer
Lung cancer remains the leading cause of cancer-related death in the United States. The good news is that early detection ...
As artificial intelligence tools like ChatGPT become increasingly common in healthcare, ESMO has taken a decisive step to ensure their safe and effective use in cancer care. ESMO has unveiled its ...
Bellmunt J, Hussain M, Gschwend JE, et al. Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): A multicentre, open-label, randomized, phase 3 trial. Lancet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback